マトリックス金属タンパク質は,多発性硬化症におけるバイオマーカーである.

"When the Worlds Change and We Get Old": Indigenous Older Adults Reflecting on Dementia and Aging.

International journal of environmental research and public health·2026

MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics.

Annals of neurology·2025

White matter free water mediates the associations between placental growth factor, white matter hyperintensities, and cognitive status.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024

Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2024

Barriers of the CNS transfer rate dynamics in patients with vascular cognitive impairment and dementia.

Frontiers in aging neuroscience·2024

Blood-Brain Barrier Permeability Is Associated With Cognitive Functioning in Normal Aging and Neurodegenerative Diseases.

Journal of the American Heart Association·2024

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Lancet (London, England)·2026

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Lancet (London, England)·2026

Advancing the relevance of clinical trials for older patients.

Lancet (London, England)·2026

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Lancet (London, England)·2026

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

Lancet (London, England)·2026

The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain.

Current neuropharmacology·2026

Protein Profile of Multiple Myeloma-Derived Extracellular Vesicles for the Discovery of Novel Myeloma-Related Biomarkers.

Cancer science·2026

Two-photon imaging microscopy of non-stained human epiretinal membranes.

Biomedical optics express·2026

Disseminated Culture-Negative Periprosthetic Knee Infection With Multifocal Septic Arthritis Associated With Mycoplasma pneumoniae: A Case Report.

Case reports in orthopedics·2026

Lung Infection Due to Species Infrequently Isolated in the Community Setting: Klebsiella variicola and Acinetobacter baumannii.

Cureus·2026

Associated Factors on Cytomegalovirus Reactivation in Patients with COVID-19 in the Intensive Care Unit.

Mediterranean journal of hematology and infectious diseases·2026

関連する実験動画

マトリックス金属タンパク質は,多発性硬化症におけるバイオマーカーである

関連する概念動画

"When the Worlds Change and We Get Old": Indigenous Older Adults Reflecting on Dementia and Aging.

MarkVCID2 Consortium for Clinical Validation of Biomarkers of Cerebral Small Vessel Disease: Validation Framework and Baseline Characteristics.

White matter free water mediates the associations between placental growth factor, white matter hyperintensities, and cognitive status.

Biological validation of peak-width of skeletonized mean diffusivity as a VCID biomarker: The MarkVCID Consortium.

Barriers of the CNS transfer rate dynamics in patients with vascular cognitive impairment and dementia.

Blood-Brain Barrier Permeability Is Associated With Cognitive Functioning in Normal Aging and Neurodegenerative Diseases.

1-month versus 12-month dual antithrombotic therapy after percutaneous coronary intervention in patients with atrial fibrillation (OPTIMA-AF): a multicentre, open-label, hybrid non-inferiority and superiority, randomised, controlled trial.

Multidomain lifestyle intervention for the prevention of cognitive decline in at-risk older adults in Latin America (LatAm-FINGERS): a single-blind, multicentre, randomised controlled trial.

Advancing the relevance of clinical trials for older patients.

Temocillin versus carbapenems for bacteraemia due to third-generation cephalosporin-resistant Enterobacterales in Spain (ASTARTÉ): a multicentre, phase 3, open-label, non-inferiority, randomised clinical trial.

Fixed-duration pirtobrutinib plus venetoclax-rituximab versus venetoclax-rituximab for patients with previously treated chronic lymphocytic leukaemia or small lymphocytic lymphoma (BRUIN CLL-322): an open-label, multicentre, randomised, controlled, phase 3 trial.

Children in all policies: lessons from a global collaboration to promote the health and wellbeing of children and future generations.

The Role of the Mitochondrial Permeability Transition Pore in Chronic Pain.

Protein Profile of Multiple Myeloma-Derived Extracellular Vesicles for the Discovery of Novel Myeloma-Related Biomarkers.

Two-photon imaging microscopy of non-stained human epiretinal membranes.

Disseminated Culture-Negative Periprosthetic Knee Infection With Multifocal Septic Arthritis Associated With Mycoplasma pneumoniae: A Case Report.

Lung Infection Due to Species Infrequently Isolated in the Community Setting: Klebsiella variicola and Acinetobacter baumannii.

Associated Factors on Cytomegalovirus Reactivation in Patients with COVID-19 in the Intensive Care Unit.

関連する実験動画

マトリックス金属タンパク質は,多発性硬化症におけるバイオマーカーである

関連する概念動画

関連記事